The Buzz Show: AirBNB (NASDAQ: ABNB) Begins Trading at USD 146 in Public Market Debut financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
FinancialBuzz.com’s latest
The Buzz Show: Featuring Our Corporate News Recap on “Immutep Limited Rise on Positive Breast Cancer Data”
Immutep Limited (NASDAQ: IMMP) opened 224% higher than its previous close after announcing that its Chinese partner, EOC Pharma is to commence a new Phase II clinical trial in up to 152 metastatic breast cancer patients in China.
The trial will evaluate Immutep’s lead product candidate eftilagimod alpha in combination with paclitaxel in HER2-negative/HR positive metastatic breast cancer patients.
Immutep is a globally active biotechnology company that is a leader in the development of LAG-3 related immunotherapeutic products for the treatment of cancer and autoimmune disease. Immutep is dedicated to leveraging its technology and expertise to bring innovative treatment options to market for patients.